Beacon Light Behavioral Health System, an affiliate of Journey Health System, is now offering BrainsWay’s Deep Transcranial ...

Achieved record quarterly sales of $11.4 millionin Q4 2024, an increase of 27% compared with Q4 2023Fullyear 2024 revenue increasednearly 30%YoY ...

Neuronetics, Inc. (NASDAQ: STIM) has released its 2024 financial results, detailing significant operational progress and ...

Q4 2024 Earnings Call Transcript March 4, 2025 Neuronetics, Inc. misses on earnings expectations. Reported EPS is $-0.33 EPS, expectations were $-0.26. Operator: Good day, and thank you for standing ...

The global depression treatment market, valued at USD 11 billion in 2024, is poised for steady growth, projected to reach USD 18.3 billion by 2034 at a CAGR of 5.2%. This expansion is driven by ...

Operating expenses during the fourth quarter of 2024 were $25.8 million, an increase of $5.6 million, or 28%, compared to $20.2 million in the fourth quarter of 2023, mainly attributable to ...

Tools for advanced health treatments can help you fine tune your fitness and health goals. Try out DEXA scans, red light ...

Repetitive transcranial magnetic stimulation (rTMS) is considered a safe treatment option for alleviating chronic pelvic pain, but different stimulation protocols can affect pain relief outcomes.

Fixed costs and variable costs are the two major inputs used by a company's management team to determine budgets and control expenses in relation to revenues. Unlike variable costs, which change ...

Simply sign up to the Artificial intelligence myFT Digest -- delivered directly to your inbox. Big Tech’s growing use of data centres has created related public health costs valued at more than ...

Wednesday afternoon, Indiana Governor Mike Braun signed an executive order regarding Medicaid costs for Applied Behavior Analysis therapy, or ABA therapy.